Please Wait
Applying Filters...

Approved Drug Products containing MolPort-000-883-856 listed in the FDA Orange Book. Original Data : FDA Website

Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3GLAXOSMITHKLINE

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass
Left Arrow
Right Arrow

01

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

AMPRENAVIR

Brand Name : AGENERASE

Dosage Form : CAPSULE;ORAL

Dosage Strength : 50MG

Approval Date : 1999-04-15

Application Number : 21007

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank

02

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

AMPRENAVIR

Brand Name : AGENERASE

Dosage Form : CAPSULE;ORAL

Dosage Strength : 150MG

Approval Date : 1999-04-15

Application Number : 21007

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank

03

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

AMPRENAVIR

Brand Name : AGENERASE

Dosage Form : SOLUTION;ORAL

Dosage Strength : 15MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date : 1999-04-15

Application Number : 21039

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

blank